Oncolytics Biotech is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of cancers. The Company is conducting clinical studies using REOLYSIN®, its proprietary formulation of the human reovirus, in some of the most prevalent forms of the disease including lung, colorectal, and pancreatic cancers.
How to communicate the drug creation process to investors and patients, while keeping them interested?
Strategy development: industry analysis, personas, themes, persona journey, strategy, tactical mix.
Content generation to be used across all communication channels.
Social Media promotion campaigns.
Improved social media engagement metrics by over 2000% in the first 6 months (comments, shares, Likes)
Increased follower counts by over 80% to date.
Since February 2015, the stock price has also seen noticeable improvement, on average of about 15%.
Additional benefits include media coverage, such as invitations to guest blog and appear on a podcast, and increased brand awareness as seen by brand reach.